Chromosomal Abnormalities in CancerFRÖHLING, Stefan; DÖHNER, Hartmut.The New England journal of medicine. 2008, Vol 359, Num 7, pp 722-734, issn 0028-4793, 13 p.Article

Génomique des leucémies aiguës myéloïdes de l'adulteDÖHNER, Hartmut.Hématologie (Montrouge). 2010, Vol 16, pp 9-15, issn 1264-7527, 7 p., NS2Article

Cancer vaccines for patients with acute myeloid leukemia : definition of leukemia-associated antigens and current clinical protocols targeting these antigensGREINER, Jochen; DOHNER, Hartmut; SCHMITT, Michael et al.Haematologica (Roma). 2006, Vol 91, Num 12, pp 1653-1661, issn 0390-6078, 9 p.Article

Hematologic malignanciesHORNING, Sandra J; ANDERSON, Kenneth C; DÖHNER, Hartmut et al.Journal of clinical oncology. 2005, Vol 23, Num 26, issn 0732-183X, 156 p.Serial Issue

Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia : recent advancesMROZEK, Krzysztof; DÖHNER, Hartmut; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2007, Vol 14, Num 2, pp 106-114, issn 1065-6251, 9 p.Article

Molecular genetics and its clinical relevanceSTILGENBAUER, Stephan; DÖHNER, Hartmut.Hematology/oncology clinics of North America. 2004, Vol 18, Num 4, issn 0889-8588, viii, 827-848 [23 p.]Article

Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemiaVOSS, Tilman; AHORN, Horst; HABERL, Peter et al.International journal of cancer. 2001, Vol 91, Num 2, pp 180-186, issn 0020-7136Article

CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13qLIEBISCH, Peter; EPPINGER, Susanne; SCHOPFLIN, Christine et al.Haematologica (Roma). 2005, Vol 90, Num 4, pp 489-493, issn 0390-6078, 5 p.Article

Risk categories and refractory CLL in the era of chemoimmunotherapyZENZ, Thorsten; GRIBBEN, John G; HALLEK, Michael et al.Blood. 2012, Vol 119, Num 18, pp 4101-4107, issn 0006-4971, 7 p.Article

Soluble CD 14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoSEIFLERT, Martina; SCHULZ, Angela; OHL, Sibylle et al.Blood. 2010, Vol 116, Num 20, pp 4223-4230, issn 0006-4971, 8 p.Article

Prognostic and therapeutic significance of myeloma genetics and gene expression profilingSTEWART, A. Keith; FONSECA, Rafael.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6339-6344, issn 0732-183X, 6 p.Article

Molecular pathogenesis of diffuse large B-cell lymphomaLOSSES, Isidore S.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6351-6357, issn 0732-183X, 7 p.Article

Current treatment approaches for mantle-cell lymphomaWITZIG, Thomas E.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6409-6414, issn 0732-183X, 6 p.Article

Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemiaFROHLING, Stefan; KAYSER, Sabine; MAYER, Cora et al.Haematologica (Roma). 2005, Vol 90, Num 2, pp 194-199, issn 0390-6078, 6 p.Article

Immunotherapy for non-Hodgkin's lymphoma : Monoclonal antibodies and vaccinesMALONEY, David G.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6421-6428, issn 0732-183X, 8 p.Article

Cytogenetic evolution of follicular lymphomaVIARDOT, Andreas; BARTH, Thomas F. E; MÖLLER, Peter et al.Seminars in cancer biology. 2003, Vol 13, Num 3, pp 183-190, issn 1044-579X, 8 p.Article

Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studiesBÜCHNER, Thomas; DÖHNER, Hartmut; EHNINGER, Gerhard et al.Leukemia research. 2002, Vol 26, Num 12, pp 1073-1075, issn 0145-2126, 3 p.Article

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemiasKRAUTER, Jürgen; GÖRLICH, Kerstin; OTTMANN, Oliver et al.Journal of clinical oncology. 2003, Vol 21, Num 23, pp 4413-4422, issn 0732-183X, 10 p.Article

Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsMARCUCCI, Guido; HAFERLACH, Torsten; DÖHNER, Hartmut et al.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 475-486, issn 0732-183X, 12 p.Article

Molecular pathogenesis of Hodgkin's lymphomaRE, Daniel; KUPPERS, Ralf; DIEHL, Volker et al.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6379-6386, issn 0732-183X, 8 p.Article

Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemiaMERTENS, Daniel; WOLF, Stephan; SCHROETER, Petra et al.Blood. 2002, Vol 99, Num 11, pp 4116-4121, issn 0006-4971Article

B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regionsWOLF, Stephan; MERTENS, Daniel; SCHAFFNER, Claudia et al.Human molecular genetics (Print). 2001, Vol 10, Num 12, pp 1275-1285, issn 0964-6906Article

Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia CellsGREINER, Jochen; BULLINGER, Lars; GUINN, Barbara-Ann et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7161-7166, issn 1078-0432, 6 p.Article

Risk stratification in chronic lymphocytic leukemiaSEILER, Till; DÖHNER, Hartmut; STILGENBAUER, Stephan et al.Seminars in oncology. 2006, Vol 33, Num 2, pp 186-194, issn 0093-7754, 9 p.Article

Page / 6